Efficacy and safety of vaginally administered lyophilized Lactobacillus crispatus IP 174178 in the prevention of bacterial vaginosis recurrence

J.M. Bohbot1, E. Daraï2, F. Bretelle3, G. Brami4, C. Daniel4, J.M. Cardot5
1Institut Alfred-Fournier, 75014, Paris, France
2Service de gynécologie-obstétrique et médecine de la reproduction, hôpital Tenon, université Pierre-et-Marie-Curie, UMRS 938, AP–HP, 75020 Paris, France
3Department of gynaecology and obstetrics, gynépole, AMU, Aix-Marseille université, UM63, CNRS 7278, IRD 198, Inserm 1095, Assistance publique–Hôpitaux de Marseille, 13005 Marseille, France
4Laboratoires IPRAD PHARMA, 174, quai de Jemmapes, 75010 Paris, France
5Université Clermont-Auvergne, UMR MEDIS, CHU de Clermont-Ferrand, 63000 Clermont-Ferrand, France

Tài liệu tham khảo

Livengood, 2009, Bacterial vaginosis: an overview for 2009, Rev Obstet Gynecol, 2, 28 Kenyon, 2013, The global epidemiology of bacterial vaginosis: a systematic review, Am J Obstet Gynecol, 209, 505, 10.1016/j.ajog.2013.05.006 Lepargneur, 2016, Lactobacillus crispatus as a biomarker of the healthy vaginal tract, Ann Biol Clin, 74, 421 Schwebke, 2005, Risk factors for bacterial vaginosis in women at high risk for sexually transmitted diseases, Sex Transm Dis, 32, 654, 10.1097/01.olq.0000175396.10304.62 Muzny, 2014, 3rd Sexual partnership characteristics of African American women who have sex with women; impact on sexually transmitted infection risk, Sex Transm Dis, 41, 611, 10.1097/OLQ.0000000000000194 Fethers, 2008, Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis, Clin Infect Dis, 47, 1426, 10.1086/592974 Mascarenhas, 2012, Prevalence and risk factors for bacterial vaginosis and other vulvovaginitis in a population of sexually active adolescents from Salvador, Bahia, Brazil, Infect Dis Obstet Gynecol, 378640 Klebanoff, 2010, Personal hygienic behaviors and bacterial vaginosis, Sex Transm Dis, 37, 94, 10.1097/OLQ.0b013e3181bc063c Li, 2014, Risk factors for bacterial vaginosis: results from a cross-sectional study having a sample of 53,652 women, Eur J Clin Microbiol Infect Dis, 33, 1525, 10.1007/s10096-014-2103-1 Leitich, 2003, Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis, Am J Obstet Gynecol, 189, 139, 10.1067/mob.2003.339 Dingens, 2016, Bacterial vaginosis and adverse outcomes among full-term infants: a cohort study, BMC Pregnancy Childbirth, 16, 278, 10.1186/s12884-016-1073-y Atashili, 2008, Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies, AIDS, 22, 1493, 10.1097/QAD.0b013e3283021a37 Bilardi, 2013, The burden of bacterial vaginosis: women's experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis, PloS One, 8, e74378, 10.1371/journal.pone.0074378 Amsel, 1983, Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations, Am J Med, 74, 14, 10.1016/0002-9343(83)91112-9 Sherrard, 2001, Management of syndromes. European guideline for the management of vaginal discharge, Int J STD AIDS, 12, 73, 10.1258/0956462011923985 Canadian, 2013 Sobel, 2006, Suppressive antibacterial therapy with 0.75 % metronidazole vaginal gel to prevent recurrent bacterial vaginosis, Am J Obstet Gynecol, 194, 1283, 10.1016/j.ajog.2005.11.041 Bradshaw, 2006, High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence, JID, 193, 1478, 10.1086/503780 Swidsinski, 2005, Adherent biofilms in bacterial vaginosis, Obstet Gynecol, 106, 1013, 10.1097/01.AOG.0000183594.45524.d2 Swidsinski, 2008, An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole, Am J Obstet Gynecol, 198, 97e1, 10.1016/j.ajog.2007.06.039 Rossi, 2010, The use of Lactobacillus rhamnosus in the therapy of bacterial vaginosis. Evaluation of clinical efficacy in a population of 40 women treated for 24 months, Arch Gynecol Obstet, 281, 1065, 10.1007/s00404-009-1287-6 Vicariotto, 2014, Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis. A pilot study, J Clin Gastroenterol, 48, S106, 10.1097/MCG.0000000000000226 Mastromarino, 2009, Effectiveness of Lactobacillus containing vaginal tablets in the treatment of symptomatic bacterial vaginosis, Clin Microbiol Infect, 15, 67, 10.1111/j.1469-0691.2008.02112.x Larsson, 2008, Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study, BMC Womens Health, 8, 3, 10.1186/1472-6874-8-3 Ya, 2010, Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study, Am J Obstet Gynecol, 203, 120e1, 10.1016/j.ajog.2010.05.023 Mc Lean, 2000, Characterization and selection of Lactobacillus species to re-colonise the vagina of women with recurrent vaginosis, J Med Microbiol, 49, 543, 10.1099/0022-1317-49-6-543 Atassi, 2006, Lactobacillus strains isolated from the vagina microbiota of healthy women inhibit Prevotella bivia and Gardnerella vaginalis in co-culture and cell culture, FEMS Immunol Med Microbiol, 48, 424, 10.1111/j.1574-695X.2006.00162.x Schwebke, 1996, Validity of the vaginal gram stain for the diagnosis of Bacterial vaginosis, Obstet Gynecol, 88, 573, 10.1016/0029-7844(96)00233-5 Landers, 2004, Predictive value of the clinical diagnosis of lower genital tract infections in women, Am J Obstet Gynecol, 190, 1005, 10.1016/j.ajog.2004.02.015 Senok, 2009, Probiotics for the treatment of bacterial vaginosis (Review), Cochrane Database Syst Rev, 10.1002/14651858.CD006289.pub2